Fluorescence-Guided Surgery Systems Market
完整報告名稱與涵蓋範圍
Fluorescence-Guided Surgery Systems Market Size, Share & Trends Analysis Report, By Product (Fluorescence Imaging Systems (Open Surgery, Laparoscopic and Robotic), Imaging Agents and Contrast Dyes (Indocyanine Green and Targeted Agents), Software, Visualization and Quantification Tools, Accessories and Consumables), By Imaging Agent Type (Non-Targeted Agents (Indocyanine Green and Related Dyes), Targeted Molecular Imaging Agents), By Application (Surgical Oncology and Tumor Margin Assessment, Perfusion and Anastomosis Assessment, Lymphatic Mapping and Sentinel Node Identification, Bile Duct, Ureter and Critical Structure Visualization), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The fluorescence-guided surgery systems market covers near-infrared and visible fluorescence imaging systems for open, laparoscopic and robotic surgery, the non-targeted and targeted imaging agents that generate contrast, visualization and quantification software and associated consumables, applied to tumor margin assessment, perfusion evaluation, lymphatic mapping and critical structure identification. Conventional white-light endoscopes and diagnostic radiology imaging are excluded.
Indocyanine green imaging has become routine for perfusion and lymphatic assessment in colorectal, hepatobiliary, plastic and gynecologic surgery, embedded in endoscopy towers and robotic platforms, while the first approvals of targeted molecular imaging agents for ovarian and lung cancer have opened a new phase in which tumor-specific fluorescence guides resection. Growth is supported by evidence that fluorescence reduces anastomotic leak and improves nodal detection, by the integration of fluorescence into standard visualization systems and by a pipeline of tumor-targeted agents across breast, brain, prostate and gastrointestinal cancers. Reimbursement for imaging agents, quantification standards and the need for surgeon training shape adoption, and agent developers partner with system vendors to align optics with new fluorophores.
North America and Europe lead adoption, with Japan, China and South Korea expanding as endoscopy and robotic platforms incorporate fluorescence. Competition involves surgical visualization leaders, microscope and camera specialists, robotics companies and imaging agent developers.
The InsightAce study includes revenue forecasts in US$ for all product, imaging agent type, application and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Fluorescence-Guided Surgery Systems Market Snapshot
Chapter 4. Global Fluorescence-Guided Surgery Systems Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. Product & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product:
5.2.1. Fluorescence Imaging Systems (Open Surgery, Laparoscopic and Robotic)
5.2.2. Imaging Agents and Contrast Dyes (Indocyanine Green and Targeted Agents)
5.2.3. Software, Visualization and Quantification Tools
5.2.4. Accessories and Consumables
Chapter 6. Market Segmentation 2: By Imaging Agent Type Estimates & Trend Analysis
6.1. Imaging Agent Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Imaging Agent Type:
6.2.1. Non-Targeted Agents (Indocyanine Green and Related Dyes)
6.2.2. Targeted Molecular Imaging Agents
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Surgical Oncology and Tumor Margin Assessment
7.2.2. Perfusion and Anastomosis Assessment
7.2.3. Lymphatic Mapping and Sentinel Node Identification
7.2.4. Bile Duct, Ureter and Critical Structure Visualization
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Hospitals and Surgical Centers
8.2.2. Ambulatory Surgical Centers
8.2.3. Academic and Research Institutions
Chapter 9. Fluorescence-Guided Surgery Systems Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Stryker Corporation
11.2. KARL STORZ SE & Co. KG
11.3. Olympus Corporation
11.4. Medtronic plc
11.5. Carl Zeiss Meditec AG
11.6. Leica Microsystems (Danaher)
11.7. Lumicell, Inc.
11.8. OnLume Surgical
11.9. Bracco Imaging S.p.A. (SurgVision)
11.10. Getinge AB (Fluoptics)
11.11. Intuitive Surgical, Inc. (Firefly)
11.12. Hamamatsu Photonics K.K.
11.13. Quest Photonic Devices B.V.
11.14. Shimadzu Corporation
11.15. Vergent Bioscience, Inc.
圖表清單 List of Tables & Figures
Table 1. Global Fluorescence-Guided Surgery Systems Market Revenue Forecast by Product, 2026-2035 (US$ Mn)
Figure 1. Global Fluorescence-Guided Surgery Systems Market Segmentation Overview
Table 2. Global Fluorescence-Guided Surgery Systems Market Revenue Forecast by Imaging Agent Type, 2026-2035 (US$ Mn)
Figure 2. Global Fluorescence-Guided Surgery Systems Market Share by Product, 2026 & 2035
Table 3. Global Fluorescence-Guided Surgery Systems Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Fluorescence Applications Across Perfusion, Lymphatic Mapping and Tumor Margin Assessment
Table 4. Global Fluorescence-Guided Surgery Systems Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Global Fluorescence-Guided Surgery Systems Market Share by Imaging Agent Type, 2026 & 2035
Table 5. North America Fluorescence-Guided Surgery Systems Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Targeted Imaging Agent Pipeline by Cancer Type and Regulatory Status, 2026
Table 6. Europe Fluorescence-Guided Surgery Systems Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Fluorescence-Guided Surgery Systems Growth Opportunity Analysis
Table 7. Asia Pacific Fluorescence-Guided Surgery Systems Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Integration of Fluorescence Imaging into Endoscopy Towers and Robotic Platforms
Table 8. Latin America Fluorescence-Guided Surgery Systems Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Fluorescence-Guided Surgery Systems Market Participants
Table 9. Middle East & Africa Fluorescence-Guided Surgery Systems Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們